Stimulating Health Innovation Collaborations
Inviting all public and private innovators/inventors to pitch
14 April 2016
noon to 9:00pm
University of Canberra
Ann Harding Conference Centre
Only -46 days left until the event!Register Now
REALISE is a dynamic community of entrepreneurs, scientists, medical professionals, innovators, investors, industry leaders and economic development personnel, working together to improve healthcare using technology and innovation. REALISE promotes collaboration within the healthcare innovation community to bring innovative products and services to market, with the ultimate goal of improving patient care.
Meet some of Australia’s brightest innovators and big thinkers in health tech at the inaugural REALISE Pitch & Connect Event.
The one-day event promotes collaborations between innovators, inventors and entrepreneurs who have synergistic goals and aspirations. Innovators, inventors and entrepreneurs will give a three-minute pitch to event attendees, followed by networking opportunities. Our aim is that parties with similar interests will leave the event with an action plan for collaboration, which will contribute towards achieving each party’s goal.
Hospital & Ambulance Executives, Surgical Teams, CBRIN Members, IP Commercialisation Professionals, Academics & Researchers, Clinicians, Medical Support Staff, Paramedic Staff, Startups & Entrepreneurs, Investors & Advisors, Patent Attorneys, Economic Development Personnel, Students, Media and Promotions Staff, Inventors & Innovators, Health Administration Staff, IP Governance Staff, Lawyers, Innovative Corporations, Policy Makers.
Come along and meet other CBR innovators in health. We're here to help make Canberra the place for health innovators to succeed. We'll take it in turn to host get-togethers, where we will share ideas over a few drinks and food.Who Should Attend? Anyone with an interest in health innovation and commercialisation! All are welcome, and here are few of the groups from our community:-Hospital, Allied Health and Ambulance Executives - IP Commercialisation Proffesionals - Researches - Clinicians - Medical Support staff - Paramedic staff - Health Administration staff - Policy Makers - IP Governance staff - Investors and Advisors - Patent Attorneys - Lawyers - Students
Minister for Higher Education, Training and Research
(February 2016 - Present)
Minster for Transport and Municipal Services
(February 2016 - Present)
Assistant Minister for Health
(February 2016 - Present)
ALP Caucus Secretary
(January 2015 – Present)
|Mr Noman Masood||Northern Sydney Local Health District||eASY - The Electronic Antibiotic Stewardship sYstem|
|Mr Noman Masood||Northern Sydney Local Health District||The eASYAPP|
|Mr Marcus Dawe||Health Innovate Pty Ltd||Health Horizon: all the world’s health innovations in one place|
|Guy McKenna||mi-BRAIN||Development of a non-invasive personal device that has applications for medical, education and entertainment use|
|Dr Lisa Scharoun||University of Canberra||Award winning, innovative child health record for monitoring baby vaccinations|
Jacqueline is Head of Investment Strategy at iQX Limited and Fund Manager for the iQ Series 8 Funds. She is a senior investment banker with over 24 years’ professional experience across EMEA-US-APAC.
Jacqueline was previously Senior Director at BNP Paribas-Fortis Europe. In the UK, she served also as Global Head of M&A Advisory and Structured Alternatives where she spearheaded and developed the platform, growing the global portfolio to USD15+billion.Prior to Europe, Jacqueline worked at Bankers Trust Alex. Brown Australia in Acquisitions and Structured Finance. She started her career at Ernst & Young New Zealand and Hong Kong in Advisory, M&A and Restructuring.
Jacqueline is Head of Investment Strategy at iQX Limited and Fund Manager for the iQ Series 8 Funds. The first in the series is the iQ Series 8 Life Science Fund (Global) ESVCLP LP AUD100million fund. The Fund invests in early-stage private life science companies - primarily focused on biotechnology innovations - that are actively involved in the late discovery or preclinical development stages of new medicines or medical technologies.
Jacqueline is a senior investment banker with over 24 years’ professional experience across EMEA-US-APAC. She holds solid global transaction track record in landmark cross-border M&As, complex Structured Finance and Alternative Investments.
Recently returning to Australia, Jacqueline was previously Senior Director at BNP Paribas-Fortis Europe where she held positions as Executive Director of Fortis Corporate, Institutional and Investment Banking United Kingdom; and, as Director of Fortis Corporate and Investment Banking Netherlands, with a period in the United States working on Structured Equities. In the UK, she served also as Global Head of M&A Advisory and Structured Alternatives where she spearheaded and developed the platform, growing the global portfolio to USD15+billion. The portfolio included Special Situations Fund and Structured Alpha Fund.
Prior to Europe, Jacqueline was Senior Manager at Bankers Trust Alex. Brown Australia in Acquisitions and Structured Finance; and before that, she worked at Ernst & Young New Zealand and Hong Kong in Advisory, M&A and Restructuring where she was Head of Special Reviews.
Jacqueline previously served as Board Member of CWN London in the UK and Chaired the Business Committee, focusing on entrepreneurial new ventures; and, Board Member of MC Investment Advisers Singapore, focusing on Asia Development Funds. She also served as guest specialist on the Economist Intelligence Unit European Capital Markets Panel in London, and on the NYSE Euronext-Alternext co-sponsored European Mid-Caps Investors Panel in Paris. She was a keynote speaker at The Brilliant Conference 2015.
Jacqueline graduated summa cum laude. She holds a specialist Masters in International Finance and Economics - MIF degree awarded with Distinction (1st) conferred jointly by University of Amsterdam Graduate Business School and Graduate Faculty of Economics & Econometrics; and, a triple major Bachelors of Commerce in Management Science, Accountancy and Finance, with Distinction Honours in Commercial Law from University of Canterbury. She has postgraduate certification in European Politics & EU Policies from Utrecht University, and professional certification from The Chartered Institute for Securities & Investments UK. Jacqueline is a C.A. Member of CAANZ and an ASEAN Scholar.
|Dr Braden McGrath||nuCoria||nuCoria Field Analyser (nCFA)|
|Professor Paul Smith||The Canberra Hospital, ACT Health||FractureNet - a decision support database for Orthopaedic Surgeons|
The Ann Harding Conference Centre is a lovely place to hold events and has the flexibility to deal with both small and large groups. Professor Rachel Davey
Director, Centre for Research & Action in Public Health, Faculty of Health
We appreciate the location, ease of parking, bright and spacious foyer and fantastic conference facilities. Bronwyn Parsons
Education Program Officer, ACT Medicare Local
I have been extremely impressed with the state-of-the-art audio-visual facilities, including the dual large screen video conferencing, impressive sound system and wireless network access. Murray Rankin
Managing Director and Chief Executive
Limited available seats Get your Tickets early.
The event is made possible with assistance from the ACT Government under the CBR Innovation Development Fund
University of Canberra - Ann Harding Conference Centre
University of Canberra
Ann Harding Conference Centre Bldg 24
University Drive South BRUCE ACT 2617
Hospital Intellectual Property Group Ltd
Project Lead: Dr Deborah Kuchler M: 0418 726622
Enquiries: Ms Tina Croker M: 0408 165 062 Tina.Croker@realise.org.au
Media: Ms Jessica Beange M: 0439 646 email@example.com
The University of Canberra has introduced pay parking on campus between the hours of 7am and 7pm, Monday to Friday. .Driving distances: Canberra Airport: 17 mins, National Convention Centre: 10 mins, CBD Centre: 11 mins, Parliament House: 15 mins